Day 2 of the 19th Annual NY GU Cancers Congress is in full swing! Check out onclive.com for all of our coverage of the meeting #oncology #kcsm #RCC #prostatecancer
0
0
0
0
#ProstateCancer
Latest posts tagged with #ProstateCancer on Bluesky
Trending
#U.S. Foreign Policy
#F1
#Chinese Grand Prix
#SNL
#Venezuela Baseball
#AEW Collision
#Six Nations
#Newcastle United
#Arsenal vs Everton
#Trump and Epstein
#U.S. Foreign Policy
#F1
#Chinese Grand Prix
#SNL
#Venezuela Baseball
#AEW Collision
#Six Nations
#Newcastle United
#Arsenal vs Everton
#Trump and Epstein
Posts tagged #ProstateCancer
Great discussion this morning at #EAU26 on health literacy and shared decision making for vulnerable patients with prostate cancer.
Thanks to everyone that joined the session! 💙
#CLEARPC #EU4Health #ProstateCancer #HealthLiteracy
1
0
0
0
Encouraging news in prostate cancer research: pairing next-generation immunotherapy with standard hormone therapy before surgery may help overcome long-standing treatment barriers.
#ProstateCancer #Immunotherapy #CancerResearch #Oncology #TCSC
cancerletter.com/the-cancer-l...
0
0
1
0
PSA50 outcomes with lutetium Lu-177 vipivotide tetraxetan did not differ by race in patients with mCRPC, according to data from retrospective cohort study presented during @ascocancer.bsky.social #GU26 #oncology #pcsm #prostatecancer
Read more here: www.onclive.com/view/racial-...
0
0
0
0
NCHR President Diana Zuckerman told reporters this panel should include more diversity of opinion than has been seen recently.
Cancer patients deserve rigorous, transparent reviews with solid evidence.
#FDA #CancerResearch #BreastCancer #ProstateCancer
www.biospace.com/fda/two-astr...
0
0
0
0
Thank you to Maha H. Hussain, MD, FACP, FASCO, of @nufeinbergmss.bsky.social for presenting on treatment intensification in mHSPC! Stay tuned to onclive.com for all of our coverage of the 19th Annual NY GU Cancers Congress! #oncology #pcsm #ProstateCancer
0
0
0
0
PSMA PET/CT #imaging uses a molecule that highlights aggressive #ProstateCancer cells as bright spots, helping distinguish cancers that require treatment from low-risk cases to prevent #overdiagnosis.
#PSMAPETCT #EAU26
0
1
0
0
March Issue: Lymph Node Invasion Prediction in #ProstateCancer : A Comparative Machine-Learning Study
https://rdcu.be/e70D3
0
1
0
0
Dr @alison-tree.bsky.social led the TRAP trial at The Royal Marsden, exploring targeted SBRT, a precise radiotherapy, for men with advanced #ProstateCancer.
The trial looked at whether SBRT could delay chemotherapy and maintain quality of life.
📙 Read more: prostatecanceruk.org/research/res...
1
1
0
0
New #ProstateCancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort study. www.thelancet.com/journals/lan...
0
0
0
0
Podcast: Current Insights and Emerging Trends in #MolecularImaging and #Theranostics for #ProstateCancer
www.diagnosticimaging.com/view/reading...
#radiology #RadRes
0
0
0
0
Dr Jason Efsthathiou, presents PEACE-3 data: Adding Radium-223 to enzalutamide prolongs rPFS (19.4 vs 16.4 mo, HR 0.69) in #mCRPC with bone metastases. Research from Dr Enrique Gallardo.
Read the review and watch the full interview at: ➡️ https://bit.ly/4rNUPUK
#MedEd #OncTwitter #ProstateCancer
0
0
0
0
Dr. Ernie Kninjing on survival outcomes among patients with #prostatecancer , from Georgia College and State University, Georgia.
Quality of Care and Survival Outcomes Among Patients With Clinically Localized Prostate Cancer in Nigeria...
pmc.ncbi.nlm.nih.gov/articles/PMC...
0
0
0
0
📍 The CLEAR-PC project will be at #EAU26 in London this weekend!
Join us on Saturday (14 March) for two sessions on prostate cancer, health literacy, and shared decision-making.
Looking forward to connecting at the congress.
#CLEARPC #ProstateCancer #HealthLiteracy #EU4Health
3
0
0
0
🚀 Dive into #ASCOGU25 buzz!
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TRRj7w !
#Oncology #SocialListening #LucidQuest
0
0
0
0
Dr. Scott Tyldesley of UBC reports on 15-year ASCENDE-RT data: Brachytherapy boost halves PC-specific mortality (8.6% vs 16.4%, P=.007) but shows no OS benefit.
Read more here: ➡️ https://bit.ly/3OGoIaH
#pcsm #prostatecancer #ASCOGU26 #GU26
0
0
0
0
Dr. Faruk Mohammed on #prostatecancer early detection, from Ahmadu Bello University Teaching Hospital, Nigeria.
An intervention mapping approach to the development and evaluation of a community-based prostate cancer early detection...
pmc.ncbi.nlm.nih.gov/articles/PMC...
0
0
0
0
Alicia Morgans, MD, MPH, of @danafarber.bsky.social discusses data from a real-world analysis of androgen pathway receptor triplet regimens in mHSPC that were presented during the 2026 Genitourinary Cancers Symposium. #GU26 #prostatecancer #pcsm
0
0
0
0
🔷 Findings highlight how advanced imaging may refine prognosis and guide more personalized treatment strategies in prostate cancer.
🔗 Read more: bit.ly/ONCOnews-11M...
#ONCOnews #OncoAlert #OncEd #ProstateCancer #PSMAPET #Oncology #CancerResearch #CancerImaging #PrecisionMedicine #Urology #Cancer
0
0
0
0
📣 New Podcast! "S2E140- Barbie does what? Celebrity phobias and more" on @Spreaker #barbie #prostatecancer
0
0
0
0
Prostate cancer treatment is evolving.
Dendritic cell therapy in Mexico uses your own immune cells to recognize and attack tumor cells, offering a approach to cancer care.
placidway.com/answer-detail/571176/How-Effective-Is-Dendritic-Cell-Therapy-for-Prostate-Cancer-in-Mexico
#ProstateCancer
0
0
0
0
Scientific Paper published in British Journal of Cancer, titled: Inhibition of c-FLIP alongside TRAIL treatment suppresses prostate cancer stem cell activity. Written by Turnham et al.
Could inhibiting c-FLIP enhance the effectiveness of docetaxel in men with #ProstateCancer?
Exciting new research from Cardiff University, led by Prof Richard Clarkson and Dr Daniel Turnham, has been published in British Journal of Cancer.
Grab a ☕ and read: doi.org/10.1038/s414...
0
0
0
0
Could Pluvicto Be Utilized for Earlier Treatment of #ProstateCancer?
www.diagnosticimaging.com/shorts/pluvi...
#radiology #RadRes #RadOnc
0
0
0
0
Trial Tuesday! Dr. Deepak Kilari from Medical College of Wisconsin is now enrolling Alliance for Clinical Trials in Oncology A032302, the ASPIRE trial to see if adding chemo to hormone therapy improves survival in men with metastatic #prostatecancer. Learn more at http://bit.ly/AllianceA032302
0
0
0
0
Happy birthday, Dad!
I miss you.
I love you.
#ProstateCancer #ProstateCancerAwareness #Stage4ProstateCancer #Stage4ProstateCancerAwareness #StageFourProstateCancer #StageFourProstateCancerAwareness #Stage4MetastasizedProstateCancer #StageFourMetastasizedProstateCancer #ProstateExamsSaveLives
1
0
1
0
At the ICR, we discover more prototype cancer drugs than any other academic institution in the world.
One drug we discovered, abiraterone, has helped to give thousands of men with advanced #ProstateCancer, many more years with their loved ones.
www.icr.ac.uk/about-us/icr...
0
1
1
0
News From Industry: AMPLITUDE Update
Source: GlobeNewswire
www.globenewswire.com/news-release...
European Commission approves niraparib + abiraterone acetate w/ prednisone/prednisolone & androgen deprivation therapy for patients with BRCA1/2-mutated metastatic hormone-sensitive #ProstateCancer
0
0
0
0
FDA Approves New Formulation of the #PSMA PET Agent Pylarify
www.diagnosticimaging.com/view/fda-app...
#radiology #RadRes #ProstateCancer
0
0
0
0
Can cancer change how someone sees life?
A stage 4 prostate cancer survivor reflects on resilience, gratitude, and the unexpected lessons that can emerge from the cancer journey.
#CancerSurvivor #ProstateCancer #CancerJourney #TCSC
www.curetoday.com/view/can-can...
1
0
1
0
Two graphs display survival probabilities over time, stratified by BRS. Graph A shows the ACIS cohort, while graph B shows the ELM-PC-5 cohort. Each graph plots four BRS groups, 0 to 3, with decreasing survival probability as BRS increases. Text@1 shows statistical significance.
The Bellmunt Risk Score stratified #ProstateCancer survival and progression risk in patients with metastatic castration-resistant disease, supporting its utility for baseline prognostication in clinical care.
ja.ma/4b63b2K
0
0
0
0